Internal Medicine, Critical Care Medicine · Memphis, TN
NPI
1235110313
Since 2005
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5050 Poplar Ave, Suite 800
Memphis, TN, 38157
Phone (901) 276-2662
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
3,407 services
Medicare patients, 2024
768
Average age 76
Drug cost, 2024
$3.0M
1,696 prescriptions
Company payments, 2025
$2,399
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul R Deaton was code 99232 (hospital e&m - subsequent), 623 times for 310 patients. In total Paul R Deaton billed 3,407 services in 51 codes, and Medicare paid $162K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 623 | 310 | $58.88 | $37K |
| 99214 Office E&M - Established | Office | 316 | 218 | $87.83 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 309 | 112 | $87.25 | $27K |
| 99213 Office E&M - Established | Office | 193 | 146 | $58.31 | $11K |
| 71046 X-ray - Chest | Office | 174 | 143 | $21.86 | $3,804 |
| 99222 Hospital E&M - Initial | Facility | 150 | 144 | $91.53 | $14K |
| 94010 Pulmonary Function Testing | Office | 149 | 132 | $18.16 | $2,706 |
| 71250 CT/CTA - Chest | Office | 97 | 80 | $98.18 | $9,523 |
| 99231 Hospital E&M - Subsequent | Facility | 92 | 88 | $36.41 | $3,350 |
| 99204 Office E&M - New | Office | 43 | 43 | $113.89 | $4,897 |
| 94729 Pulmonary Function Testing | Office | 31 | 26 | $35.22 | $1,092 |
| 99223 Hospital E&M - Initial | Facility | 28 | 28 | $133.40 | $3,735 |
| G0008 Administration of influenza virus vaccine | Office | 19 | 19 | $29.78 | $566 |
| 99291 Critical Care E&M | Facility | 18 | 18 | $158.02 | $2,844 |
| 90662 Vaccine Product | Office | 18 | 18 | $80.72 | $1,453 |
By year: 2022 $162K for 3,320 services; 2023 $180K for 2,886 services; 2024 $162K for 3,407 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 15 | $8.14 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul R Deaton prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 202 prescriptions and refills. In total Paul R Deaton wrote 1,696 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 202 | 226 | 77 | $5,217 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 170 | 241 | 38 | $148K |
| Breo Ellipta Fluticasone/Vilanterol | 103 | 137 | 27 | $54K |
| Prednisone Generic | 100 | 127 | 42 | $408 |
| Azithromycin Generic | 83 | 111 | 24 | $2,041 |
| Spiriva Respimat Tiotropium Bromide | 78 | 112 | 20 | $56K |
| Ventolin Hfa Albuterol Sulfate | 51 | 55 | 14 | $3,255 |
| Montelukast Sodium Generic | 50 | 140 | 22 | $626 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 48 | 62 | Under 11 | $38K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 48 | 64 | 11 | $29K |
| Ofev Nintedanib Esylate | 47 | 47 | Under 11 | $613K |
| Uptravi Selexipag | 35 | 35 | Under 11 | $827K |
| Opsumit Macitentan | 28 | 28 | Under 11 | $356K |
| Ethambutol Hcl Generic | 27 | 37 | Under 11 | $881 |
| Roflumilast Generic | 27 | 28 | Under 11 | $2,767 |
Brand drugs: 901 claims; generic drugs: 795 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul R Deaton $2,399 ($2,399 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $519.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 27 | $519 |
| GlaxoSmithKline, LLC. GSK | 31 | $306 |
| Genzyme Corporation SNY | 9 | $209 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $201 |
| United Therapeutics Corporation UTHR | 7 | $155 |
| Harmony Biosciences LLC HRMY | 6 | $149 |
| Verona Pharma, Inc. VRNA | 8 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $98.82 |
| Amgen Inc. AMGN | 6 | $97.5 |
| Merck Sharp & Dohme LLC MRK | 5 | $93.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.